151 related articles for article (PubMed ID: 28031894)
1. New hits as phase II enzymes inducers from a focused library with heteroatom-heteroatom and Michael-acceptor motives.
Cabrera M; de Ovalle S; Bollati-Fogolín M; Nascimento F; Corbelini P; Janarelli F; Kawano D; Eifler-Lima VL; González M; Cerecetto H
Future Sci OA; 2015 Nov; 1(3):FSO20. PubMed ID: 28031894
[TBL] [Abstract][Full Text] [Related]
2. Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents.
Couto M; de Ovalle S; Cabrera M; Cerecetto H; González M
Future Med Chem; 2015; 7(7):857-71. PubMed ID: 26061105
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.
Prochaska HJ; Talalay P
Cancer Res; 1988 Sep; 48(17):4776-82. PubMed ID: 3409219
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of induction of enzymes that protect against chemical carcinogenesis.
Talalay P
Adv Enzyme Regul; 1989; 28():237-50. PubMed ID: 2696344
[TBL] [Abstract][Full Text] [Related]
5. Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain.
Laso N; Mas S; Lafuente MJ; Llobet JM; Molina R; Ballesta A; Kensler TW; Lafuente A
Nutr Cancer; 2005; 52(1):49-58. PubMed ID: 16091004
[TBL] [Abstract][Full Text] [Related]
6. Bi-functional induction of the quinone reductase and cytochrome P450 1A1 by youngiasides via Nrf2-ARE and AhR-XRE pathways.
Yun JH; Lee SB; Lee HJ; Kim CY; Kim MA; Sohn YC; Nho CW
Biol Pharm Bull; 2010; 33(10):1650-7. PubMed ID: 20930371
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effects of Furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity.
Hwang YP; Han EH; Choi JH; Kim HG; Lee KJ; Jeong TC; Lee ES; Jeong HG
Toxicol Appl Pharmacol; 2008 May; 228(3):343-50. PubMed ID: 18255114
[TBL] [Abstract][Full Text] [Related]
8. Oxathiolene oxides: a novel family of compounds that induce ferritin, glutathione S-transferase, and other proteins of the phase II response.
Pietsch EC; Hurley AL; Scott EE; Duckworth BP; Welker ME; Leone-Kabler S; Townsend AJ; Torti FM; Torti SV
Biochem Pharmacol; 2003 Apr; 65(8):1261-9. PubMed ID: 12694867
[TBL] [Abstract][Full Text] [Related]
9. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2.
Lee SB; Kim CY; Lee HJ; Yun JH; Nho CW
Planta Med; 2009 Oct; 75(12):1314-8. PubMed ID: 19452436
[TBL] [Abstract][Full Text] [Related]
10. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells.
Miranda CL; Aponso GL; Stevens JF; Deinzer ML; Buhler DR
Cancer Lett; 2000 Feb; 149(1-2):21-9. PubMed ID: 10737704
[TBL] [Abstract][Full Text] [Related]
11. Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogens.
Talalay P; Prochaska HJ; Spencer SR
Princess Takamatsu Symp; 1990; 21():177-87. PubMed ID: 2134677
[TBL] [Abstract][Full Text] [Related]
12. Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells.
Heo YH; Kim S; Park JE; Jeong LS; Lee SK
Arch Pharm Res; 2001 Dec; 24(6):597-600. PubMed ID: 11794542
[TBL] [Abstract][Full Text] [Related]
13. Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants.
De Long MJ; Santamaria AB; Talalay P
Carcinogenesis; 1987 Oct; 8(10):1549-53. PubMed ID: 2820604
[TBL] [Abstract][Full Text] [Related]
14. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
[TBL] [Abstract][Full Text] [Related]
15. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines.
Yannai S; Day AJ; Williamson G; Rhodes MJ
Food Chem Toxicol; 1998 Aug; 36(8):623-30. PubMed ID: 9734712
[TBL] [Abstract][Full Text] [Related]
16. Activity-guided isolation of phase II enzyme inducers from buckwheat flour methanolic extracts.
Qiu RY; Wang JR; Parkin KL
J Sci Food Agric; 2018 Oct; 98(13):4911-4918. PubMed ID: 29569261
[TBL] [Abstract][Full Text] [Related]
17. Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines.
Liu RM; Vasiliou V; Zhu H; Duh JL; Tabor MW; Puga A; Nebert DW; Sainsbury M; Shertzer HG
Carcinogenesis; 1994 Oct; 15(10):2347-52. PubMed ID: 7955076
[TBL] [Abstract][Full Text] [Related]
18. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
19. A point mutation responsible for defective function of the aryl-hydrocarbon-receptor nuclear translocator in mutant Hepa-1c1c7 cells.
Numayama-Tsuruta K; Kobayashi A; Sogawa K; Fujii-Kuriyama Y
Eur J Biochem; 1997 Jun; 246(2):486-95. PubMed ID: 9208942
[TBL] [Abstract][Full Text] [Related]
20. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
Pollenz RS; Sattler CA; Poland A
Mol Pharmacol; 1994 Mar; 45(3):428-38. PubMed ID: 8145729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
